Expert Outlook: Sage Therapeutics Through The Eyes Of 14 Analysts
Expert Outlook: Sage Therapeutics Through The Eyes Of 14 Analysts
专家观点：通过14位分析师的眼睛看sage therapeutics
Providing a diverse range of perspectives from bullish to bearish, 14 analysts have published ratings on Sage Therapeutics (NASDAQ:SAGE) in the last three months.
在过去的三个月中，14位分析师从看好到看淡提供了多元的观点，发布了针对Sage Therapeutics（NASDAQ：SAGE）的评级。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他们最近的评级，展示了过去30天内的情绪演变并与之前的几个月进行了比较。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $16.64, with a high estimate of $25.00 and a low estimate of $8.00. This current average has decreased by 18.83% from the previous average price target of $20.50.
分析师对12个月价格目标的评估提供了额外的见解，呈现出一个平均目标为16.64美元，高估为25.00美元，低估为8.00美元。这个目标当前的平均值已经下降了18.83%，比之前的目标价格平均值20.50美元下降了。
Deciphering Analyst Ratings: An In-Depth Analysis
分析师评级解读：深入分析
The analysis of recent analyst actions sheds...
最近分析师的行...
登录免费看全文
登录/注册